Tsachi Tsadok Perets
Overview
Explore the profile of Tsachi Tsadok Perets including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dickman R, Brun R, Levy S, Ron Y, Rainis T, Naftali T, et al.
Neurogastroenterol Motil
. 2025 Jan;
e15002.
PMID: 39846242
Background: Proton pump inhibitors (PPI) for gastroesophageal reflux disease (GERD) are associated with a high failure rate. Our uncontrolled feasibility study aimed determining the effect of a transcutaneous electrical stimulation...
2.
Charach L, Perets T, Gingold-Belfer R, Huta Y, Ashorov O, Levi Z, et al.
Healthcare (Basel)
. 2024 Aug;
12(15).
PMID: 39120182
Background: Due to lower operational costs, health maintenance organizations (HMOs) may prioritize stool antigen testing (HpStAg) for the non-invasive diagnosis of infection over 13C-urea breath tests (13C-UBTs). The aim of...
3.
Sigall Boneh R, Assa A, Lev-Tzion R, Matar M, Shouval D, Shubeli C, et al.
Dig Dis
. 2023 Dec;
42(2):199-210.
PMID: 38043524
Introduction: Adherence to the Mediterranean diet (MD) was shown to be associated with decreased disease activity in adult patients with Crohn's disease (CD). Nevertheless, data on its association with fecal...
4.
Perets T, Huta Y, Ashorov O, Seef A, Dickman R
Ann Clin Lab Sci
. 2023 Nov;
53(5):784-788.
PMID: 37945019
Objective: The biomarker fecal calprotectin is an efficacious tool for evaluating the level of disease activity in Crohn's and Ulcerative colitis, as well as for discriminating between inflammatory bowel disease...
5.
Hoofien A, Guz-Mark A, Zevit N, Perets T, Assa A, Layfer O, et al.
JPGN Rep
. 2023 May;
2(2):e070.
PMID: 37207053
Methods: A prospective observational case control study of pediatric patients diagnosed with CD, with measurements of tissue transglutaminase IgA (TTG-IgA) and I-FABP levels at diagnosis and after 6 months of...
6.
Guz-Mark A, Perets T, Biran N, Jack Y, Zevit N, Silbermintz A, et al.
J Pediatr Gastroenterol Nutr
. 2023 May;
77(2):244-248.
PMID: 37204826
Objective: There is no gold standard to assess adherence to gluten-free diet (GFD) among patients with celiac disease (CeD). Gluten immunogenic peptides (GIPs) in urine and stool were suggested as...
7.
Huta Y, Ashorov O, Hamouda D, Boltin D, Dickman R, Perets T
Clin Lab
. 2022 Aug;
68(7).
PMID: 35975516
Background: Fecal pancreatic elastase 1 (FPE1) is an established screening test for pancreatic exocrine insufficiency (PEI), a condition that is underdiagnosed and if not treated may cause significant morbidity. The...
8.
Perets T, Ben Simon S, Ashorov O, Hamouda D, Dickman R, Turjeman S
New Microbiol
. 2022 Aug;
45(3):193-198.
PMID: 35920874
Gastrointestinal (GI) microbial populations are important in maintaining normal functioning of the GI by preventing disorders. Dysbiotic microbiota may increase the likelihood of small intestinal bacterial overgrowth (SIBO), a syndrome...
9.
Yanai H, Ungar B, Kopylov U, Sharar Fischler T, Avni Biron I, Ollech J, et al.
Therap Adv Gastroenterol
. 2022 Jan;
15:17562848211068659.
PMID: 35082920
Background: Evidence regarding the risk of immunogenicity in patients with inflammatory bowel disease (IBD) who switched anti-tumor necrosis factor alpha (anti-TNFα) therapies to a subsequent anti-TNFα (either infliximab or adalimumab)...
10.
Dickman R, Levy S, Perets T, Hazani-Pauker M, Boltin D, Schmilovitz-Weiss H, et al.
Gastroenterol Rep (Oxf)
. 2021 Sep;
9(4):323-328.
PMID: 34567564
Background: Gastroesophageal reflux disease (GERD) is a common disorder. Overall, ≤35% of GERD patients fail the standard dose of proton-pump-inhibitor (PPI) treatment. Due to the high prevalence and low satisfaction...